According to Calithera Biosciences 's latest financial reports the company's total assets are $28.67 M. A companyโs total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
Year | Total assets | Change |
---|---|---|
2022-12-31 | $28.67 M | -55.72% |
2021-12-31 | $64.75 M | -48.44% |
2020-12-31 | $0.12 B | -25.59% |
2019-12-31 | $0.16 B | 18.25% |
2018-12-31 | $0.14 B | -25.84% |
2017-12-31 | $0.19 B | 251.22% |
2016-12-31 | $54.79 M | -27.66% |
2015-12-31 | $75.75 M | -27.7% |
2014-12-31 | $0.10 B | 200.68% |
2013-12-31 | $34.84 M | 1038.69% |
2012-12-31 | $3.06 M |
Company | Total assets | differencediff. | Country |
---|---|---|---|
Gilead Sciences GILD | $62.12 B | 216,544.58% | ๐บ๐ธ USA |
Flexion Therapeutics
FLXN | N/A | N/A | ๐บ๐ธ USA |
Aeterna Zentaris AEZS | $37.01 M | 29.08% | ๐บ๐ธ USA |